Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Clinical trial NCT03524118 · COMPLETED

Trial details

NCT number: NCT03524118
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Respiratory Tract Infection Respiratory Syncytial Virus

Start date: 2018-09-20
Primary completion: 2022-09-14
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.